ArticleDrug design, development and therapy2020

Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways.

Yanshu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.